Le Lézard
Classified in: Health, Sports and recreation
Subject: WOM

Houston Dash partner with US Fertility and Shady Grove Fertility (SGF)


Shady Grove Fertility (SGF), a founding partner of US Fertility, is now the Official Fertility Partner of the Houston Dash, a professional women's soccer team.

HOUSTON, Sept. 23, 2022 /PRNewswire-PRWeb/ -- Today, the Houston Dash of the National Women's Soccer League (NWSL), announced that Shady Grove Fertility (SGF), a founding partner of US Fertility, is now the team's exclusive and official fertility partner.

SGF will support Dash players and their families, so they do not have to choose between their careers and their future family-building plans.

"We want to be leaders in supporting our teams and their families, and this partnership with Shady Grove Fertility creates an opportunity to support them in truly meaningful ways," said Dionna Widder, the Chief Revenue Officer for the Dash. "Through this partnership, we are proud to shine a light on the fertility services provided by Shady Grove Fertility for the aspiring parents and parents who want to grow their family?within our community."

US Fertility is the largest network of physician-owned and physician-led fertility practices in the United States. The network completes more than 29,000 IVF cycles annually and performs 1,000+ elective and donor egg freezing cycles annually. SGF, which is part of the US Fertility partnership, is home to 100,000 babies born from 30 years of continuous innovation, a commitment to research, and patient-centered care.

As a host city for the 2026 World Cup and by recently welcoming world-class athletes like Ebony Salmon and Maria Sanchez, Houston shines as a global spotlight for U.S. soccer. The organization builds on this momentum by leading the way for other teams in terms of fertility care for their players.

Age is the single most important factor affecting fertility for females, as conception becomes more difficult with age, and the chances of a chromosomal abnormality, miscarriage, or pregnancy complication become more common as eggs diminish in quality and quantity. The good news is that egg freezing, or oocyte cryopreservation, helps preserve future fertility all while leaving current fertility intact. SGF can help players safeguard their future fertility options, while still allowing them to continue their roles as professional athletes.

"Shady Grove Fertility knows the importance of family, and we are excited about partnering with the Dash family of athletes," shares SGF Houston physician John Crochet, M.D. "I look forward to walking alongside these incredible athletes and coaching staff as they make important and timely decisions about their family-building options."

ABOUT THE HOUSTON DASH
The Houston Dash joined the Houston Dynamo Football Club on Dec. 12, 2013, as the first expansion team of the National Women's Soccer League. The NWSL is supported by the Canadian Soccer Association and the United States Soccer Federation. It is the top-flight women's professional soccer league in North America, featuring many of the top players from the United States and Canada, as well as talent from around the world. The Dash began play in April 2014 for the start of the league's second season. The Dash captured their first league trophy, the 2020 NWSL Challenge Cup, on July 26, 2020.

The team trains at Houston Sports Park (HSP), the premier training facility in Southeast Texas, and plays at PNC Stadium in downtown Houston. For more information, log on to http://www.HoustonDynamoFC.com or call (713) 276-7500.

About US Fertility
US Fertility?is the nation's largest partnership of physician-owned and physician-led top-tier fertility practices, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit?USFertility.com.

About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 50 locations, including the newest location in Raleigh, North Carolina, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Media Contact

Jean Dzierzak, US Fertility, 301-545-1375, [email protected]

 

SOURCE Shady Grove Fertility


These press releases may also interest you

at 08:03
The American Red Cross celebrates The Church of Jesus Christ of Latter-day Saints, headquartered in Salt Lake City, for its substantial donation of $7.35 million. The gift will help purchase blood equipment and biomedical emergency vehicles and will...

at 08:00
A Canada-wide Settlement Agreement was recently reached in a class action against Cook (Canada) Inc., Cook Incorporated, and William Cook Europe APS ("Cook") related to certain inferior vena cava filter products ("IVC Filter Products") marketed and...

at 08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug...

at 08:00
Key Proteo, a pioneering proteomics diagnostics company specializing in the enhanced early detection of rare but treatable genetic disorders, today announced that it has submitted a de novo classification request to the U.S. Food and Drug...

at 08:00
Human Immunology Biosciences (HI-Biotm), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced that two abstracts have been accepted for oral presentation at the...

at 08:00
PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today announced positive interim results from the Phase 1 (Part A) clinical trial of Zolmitriptan PassPort® utilizing its...



News published on and distributed by: